Analysis of early phase and subsequent phase III stroke studies of neuroprotectants: outcomes and predictors for success

BACKGROUND: Efficacy of neuroprotective treatments for ischemic stroke was not convincingly demonstrated in clinical phase III trials so far, whereas some preceding early phase studies found neuroprotection to be beneficial. We aimed to determine the frequency with which phase III studies are preced...

Descripción completa

Detalles Bibliográficos
Autores principales: Minnerup, Jens, Wersching, Heike, Schilling, Matthias, Schäbitz, Wolf Rüdiger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922860/
https://www.ncbi.nlm.nih.gov/pubmed/24502346
http://dx.doi.org/10.1186/2040-7378-6-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922860/
https://www.ncbi.nlm.nih.gov/pubmed/24502346
http://dx.doi.org/10.1186/2040-7378-6-2

Ejemplares similares